LiveKidney.BIO
PrivateLast Round
Seed
Nov 18, 2018
Total Funding Raised
$4M
Company Overview
LiveKidney.BIO is a biotechnology company that develops proprietary, hydrogel-based cell therapy products to treat advanced kidney diseases and prevent their progression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LiveKidney.BIO Comparables
Compare LiveKidney.BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trestle Biotherapeutics | 85% | |
| eGenesis | 77% | |
| United Therapeutics | 77% |
LiveKidney.BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2018 |
Key People
Founding team and executive leadership
LiveKidney.BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Direct Insurance - Financial Investments | Seed |
| Aurum Ventures MKI | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors increased 57% MoM.
- Nov 18, 2018
$4M raised from Aurum Ventures MKI and others.
LiveKidney.BIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LiveKidney.BIO's valuation, stock price, and market status.
Is LiveKidney.BIO a public or private company?
LiveKidney.BIO is a private company.
What is the current stock price of LiveKidney.BIO?
LiveKidney.BIO is a private company with no public stock price. No recent secondary market data is available.
How much is LiveKidney.BIO worth (valuation)?
Valuation information for LiveKidney.BIO is not publicly available.
Can I buy LiveKidney.BIO stock?
LiveKidney.BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LiveKidney.BIO's last funding round?
LiveKidney.BIO's most recent funding round was Seed on November 18, 2018.
Who are the main investors in LiveKidney.BIO?
Key investors in LiveKidney.BIO include Direct Insurance - Financial Investments, Aurum Ventures MKI.
Will LiveKidney.BIO IPO soon?
No public IPO plans have been announced for LiveKidney.BIO.
How can I track LiveKidney.BIO secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LiveKidney.BIO's secondary market activity and sign up for updates.